Evidence map›Paper›PMID 33482061›Full record

ArticleACS chemical biology2021

Chemical Diversification of Simple Synthetic Antibodies.

Mariha Islam, Haixing P Kehoe, Jacob B Lissoos, Manjie Huang, Christopher E Ghadban, Greg Berumen Sánchez, Hanan Z Lane, James A Van Deventer

Open access · greenAbstract read
In one paragraph

Article in ACS chemical biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 36 citations in OpenAlex.

  1. Pharmacophore-driven antibody discovery on the yeast surface.bioRxiv : the preprint server for biology · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Exploration ofACS synthetic biology · 2022
    Article
  18. Article
  19. Engineering Proteins Containing Noncanonical Amino Acids on the Yeast Surface.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Mariha IslamChemical and Biological Engineering Department, Tufts University, Medford, Massachusetts 02155, United States.
Haixing P KehoeChemical and Biological Engineering Department, Tufts University, Medford, Massachusetts 02155, United States.
Jacob B LissoosChemical and Biological Engineering Department, Tufts University, Medford, Massachusetts 02155, United States.
Manjie HuangChemical and Biological Engineering Department, Tufts University, Medford, Massachusetts 02155, United States.
Christopher E GhadbanChemical and Biological Engineering Department, Tufts University, Medford, Massachusetts 02155, United States.
Greg Berumen SánchezChemical and Biological Engineering Department, Tufts University, Medford, Massachusetts 02155, United States.
Hanan Z LaneChemical and Biological Engineering Department, Tufts University, Medford, Massachusetts 02155, United States.
James A Van DeventerChemical and Biological Engineering Department, Tufts University, Medford, Massachusetts 02155, United States.ORCID 0000-0003-4343-6157
Tufts University · US

Funding

Discovering hybrid inhibitors for tumor microenvironment disruptionR21CA214239 · NCI · TUFTS UNIVERSITY MEDFORD · PI VAN DEVENTER, JAMES ALLEN · 2018 to 2020
$599k
NCI NIH HHS R21 CA214239
6 · The paper itself

Abstract

Antibodies possess properties that make them valuable as therapeutics, diagnostics, and basic research tools. However, antibody chemical reactivity and covalent antigen binding are constrained, or even prevented, by the narrow range of chemistries encoded in canonical amino acids. In this work, we investigate strategies for leveraging an expanded range of chemical functionality using yeast displayed antibodies containing noncanonical amino acids (ncAAs) in or near antibody complementarity determining regions (CDRs). To enable systematic characterization of the effects of ncAA incorporation on antibody function, we first investigated whether diversification of a single antibody loop would support the isolation of binding clones against immunoglobulins from three species. We constructed and screened a billion-member library containing canonical amino acid diversity and loop length diversity only within the third complementarity determining region of the heavy chain (CDR-H3). Isolated clones exhibited moderate affinities (double- to triple-digit nanomolar affinities) and, in several cases, single-species specificity, confirming that antibody specificity can be mediated by a single CDR. This constrained diversity enabled the utilization of additional CDRs for the installation of chemically reactive and photo-cross-linkable ncAAs. Binding studies of ncAA-substituted antibodies revealed that ncAA incorporation is reasonably well tolerated, with observed changes in affinity occurring as a function of ncAA side chain identity, substitution site, and the ncAA incorporation machinery used. Multiple azide-containing ncAAs supported copper-catalyzed azide-alkyne cycloaddition (CuAAC) and strain-promoted azide-alkyne cycloaddition (SPAAC) without the abrogation of binding function. Similarly, several alkyne substitutions facilitated CuAAC without the apparent disruption of binding. Finally, antibodies substituted with a photo-cross-linkable ncAA were evaluated for ultraviolet-mediated cross-linking on the yeast surface. Competition-based assays revealed position-dependent covalent linkages, strongly suggesting successful cross-linking. Key findings regarding CuAAC reactions and photo-cross-linking on the yeast surface were confirmed using soluble forms of ncAA-substituted clones. The consistency of findings on the yeast surface and in solution suggest that chemical diversification can be incorporated into yeast display screening approaches. Taken together, our results highlight the power of integrating the use of yeast display and ncAAs in search of proteins with "chemically augmented" binding functions. This includes strategies for systematically introducing small molecule functionality within binding protein structures and evaluating protein-based covalent target binding. The efficient preparation and chemical diversification of antibodies on the yeast surface open up new possibilities for discovering "drug-like" protein leads in high throughput.

Indexed as

AlkynesAmino AcidsAmino Acid SequenceAnimalsAntibody SpecificityAzidesCattleClick ChemistryComplementarity Determining RegionsCross-Linking ReagentsCycloaddition ReactionEquidaeImmunoglobulin GPeptide LibraryProtein EngineeringRabbitsAlkynesAmino AcidsAzidesComplementarity Determining RegionsCross-Linking ReagentsImmunoglobulin GPeptide Library

Identifiers

PMID33482061
PMCPMC8096149
OpenAlexW3125287691

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.